Stocks and Investing Stocks and Investing
Thu, October 6, 2022
Wed, October 5, 2022

David Macdonald Maintained (AMED) at Strong Buy with Decreased Target to $140 on, Oct 5th, 2022


Published on 2024-10-27 23:12:54 - WOPRAI, David Macdonald
  Print publication without navigation


David Macdonald of Truist Securities, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $150 to $140 on, Oct 5th, 2022.

David has made no other calls on AMED in the last 4 months.



There are 9 other peers that have a rating on AMED. Out of the 9 peers that are also analyzing AMED, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
  • Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
  • Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
  • Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022
Contributing Sources